- Home
- TNON vs PPBT Comparison
TNON vs PPBT Comparison
Compare TNON & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNON | PPBT |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8M | 2.4M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TNON | PPBT |
|---|---|---|
| Price | $2.05 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.50 | N/A |
| AVG Volume (30 Days) | ★ 215.5K | 20.3K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,944,000.00 | N/A |
| Revenue This Year | $52.65 | N/A |
| Revenue Next Year | $47.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.35 | N/A |
| 52 Week Low | $2.10 | $0.41 |
| 52 Week High | $45.50 | $5.18 |
Technical Indicators
Market Signals| Indicator | TNON | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 41.03 |
| Support Level | N/A | $0.54 |
| Resistance Level | $4.18 | $1.60 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 4.33 | 40.82 |
Price Performance
Historical ComparisonAbout TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.